Hospital-acquired pneumonia caused by Staphylococcus aureus is associated with patient morbidity and mortality, despite adequate antibiotic therapy. This illustrates the need for treatments beyond antibiotics.

The study provides evidence that complex bacterial toxins can be targeted in vivo by drug-like small molecules.